Skip to main content
. 2015 Apr 10;10(7):1291–1299. doi: 10.2215/CJN.00860115

Table 2.

Medications associated with minimal change disease and FSGS

Minimal change disease
 IFN-α and -β
 Pamidronate
 Lithium
 Nonsteroidal anti-inflammatory drugs
 Cyclooxygenase-2 inhibitors
FSGS
 IFN-α and -γ
 Pamidronate
 Lithium
 Sirolimus
 Anabolic steroids
Collapsing FSGS
 IFN-α, -β, and -γ
 Pamidronate (rarely zoledronate or alendronate)
 Anabolic steroids